Description

Description

Jardy-Met 12.5/500mg is a fixed-dose combination tablet that pairs a higher strength of Empagliflozin with a standard dose of Metformin, packaged 14 tablets to a pack. Empagliflozin, an SGLT2 inhibitor, works by prompting the kidneys to release surplus glucose through urine, while Metformin lowers blood sugar mainly by cutting down glucose production in the liver and improving the body’s sensitivity to its own insulin. This particular combination is often used for patients who need a stronger SGLT2 effect than the standard 5mg strength provides, while keeping the metformin dose at a more moderate 500mg, allowing the two active ingredients to work together in one convenient tablet.

Ingredients

Each Jardy-Met 12.5/500mg tablet contains:

• Empagliflozin – 12.5 mg
• Metformin Hydrochloride – 500 mg

The tablet additionally contains standard inactive excipients and a film coating, present only to give the tablet its structure and support easy swallowing, with no therapeutic action of their own.

Dosage Form

Jardy-Met 12.5/500mg is manufactured as a film-coated oral tablet, supplied 14 tablets per pack, taken by mouth according to a doctor’s instructions.

Uses

Jardy-Met 12.5/500mg is generally prescribed to:

• Improve blood glucose control in adults with type 2 diabetes mellitus who need a stronger SGLT2 inhibitor component alongside metformin
• Continue combination therapy for patients already stabilized on higher-dose Empagliflozin and metformin taken as two separate tablets
• Support broader diabetes management, including potential cardiovascular and kidney-related benefits associated with higher Empagliflozin exposure, when combined with a suitable diet and activity plan

It is not intended for people with type 1 diabetes or for the management of diabetic ketoacidosis.

How to Use

The points below are general guidance only — always follow the specific instructions given by your prescribing doctor:

• Take the tablet with meals, which can help reduce the digestive discomfort commonly linked to the metformin component.
• Your doctor will determine the dosing schedule based on your blood sugar readings and overall response to treatment.
• Swallow the tablet whole with a glass of water; avoid crushing or chewing it.
• Keep to a consistent daily timing to support stable blood sugar management.
• Attend recommended blood tests, including kidney function checks, since continued use depends on adequate kidney health, particularly at this higher Empagliflozin strength.

Side Effects

Side effects can vary between patients, but commonly reported ones include:

• Nausea, diarrhea, or general stomach upset, especially when treatment is first started
• Reduced appetite or a metallic taste in the mouth
• Increased urination, which may be more noticeable at this higher Empagliflozin dose
• Mild dehydration or increased thirst
• Urinary tract or genital yeast infections

Less commonly, more serious issues can occur, including a marked drop in blood pressure, lactic acidosis (a rare but serious risk tied to the metformin component, more likely with reduced kidney or liver function), or symptoms suggesting diabetic ketoacidosis such as persistent nausea, vomiting, or abdominal discomfort even when blood sugar readings look normal. Any of these require prompt medical attention. This list is not exhaustive, so any unusual reaction should be reported to a doctor or pharmacist.

Pregnancy & Breastfeeding

Jardy-Met 12.5/500mg is generally not recommended during pregnancy, since the Empagliflozin component may affect fetal kidney development, particularly in later stages of pregnancy, and diabetes management in pregnant women is typically handled through other approved treatments under specialist supervision. It is also generally not advised while breastfeeding. Women who are pregnant, planning a pregnancy, or currently breastfeeding should discuss their treatment plan with a doctor before starting or continuing this medication.

Storage Instructions

• Store Jardy-Met 12.5/500mg tablets at room temperature, ideally below 25°C, away from direct sunlight, heat, and humidity.
• Keep tablets in their original blister packaging until ready to use.
• Store out of reach of children.
• Do not use tablets past their printed expiry date, and dispose of unused medicine responsibly rather than through household waste.

FAQS

How does the 12.5/500mg strength differ from the 5/500mg version?
Both contain the same metformin dose, but this version has a higher Empagliflozin strength, often chosen when stronger SGLT2 inhibition is needed while keeping metformin at a moderate level.

Should this tablet always be taken with food?
Yes, taking it with a meal is generally recommended to help minimize metformin-related stomach discomfort.

Does the higher Empagliflozin dose increase urination noticeably?
Some patients notice a more pronounced increase in urinary frequency at this strength, which is generally expected and usually manageable with adequate fluid intake.

Is extra monitoring needed at this dose?
Yes, your doctor may recommend closer monitoring of kidney function and blood pressure, particularly when starting or adjusting to this strength.

Can Jardy-Met 12.5/500mg be used with other diabetes medications?
It can sometimes be combined with other treatments, including insulin, but only under close medical supervision due to an increased risk of low blood sugar.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.